论文部分内容阅读
<正> OBJECTIVE Pegylated liposomal doxorubicin (PLD;CAELYX~(?)), a novel formulation of doxorubicin with enhancedtherapeutic efficacy and reduced toxicity, has demonstratedimproved progression-free survival in recurrent or refractoryovarian cancer. T